I have mild COVID. Should I take the antiviral Paxlovid?

The COVID medication Paxlovid has been available in Australia on the Pharmaceuticals Benefits Scheme (PBS) since the start of May, with eligible patients directed to talk to their GP for a prescription. Paxlovid is an oral treatment for mild COVID, taken as a tablet, which has two active ingredients: nirmatrelvir and ritonavir. Together, they reduce

‘Ice Slurry’ Has Potential for Treating OSA, Other Conditions

SAN DIEGO – During her third year in the combined Harvard/Massachusetts General Hospital dermatology residency program in 2011, Lilit Garibyan, MD, PhD, attended a lecture presented by R. Rox Anderson, MD, director of the Wellman Center for Photomedicine at MGH. He described the concept of selective cryolipolysis – the method of removing fat by topical

Women More Likely to Receive Delayed Care in Trauma Centers

NEW YORK (Reuters Health) – Female patients who end up at U.S. trauma centers experience longer delays before treatment and a higher likelihood of discharge to long-term-care facilities compared with their male counterparts, a new study finds. An analysis of data from more than 28,000 patients revealed that female patients experienced significantly longer time in

Talking to your kids about the shooting tragedy in Texas

After a gunman killed at least 19 students and two teachers Tuesday at an elementary school in Uvalde, Texas, this week, horrified parents may be wondering how to talk with their children about it. From toddlers and teens to young adults, kids look to their parents to feel safe—especially so after these mass shootings that

Combined Use of Anakinra, Etanercept, and BETA-2 Score Linked With Improved Islet Cell Transplant Outcomes

NEW YORK (Reuters Health) – In a single center’s 20-year experience with pancreatic islet cell transplantation, patients with sustained graft survival were more likely to have had combination treatment with anakinra plus etanercept (one or more infusions) and a BETA-2 score of 15 or higher – reflecting insulin independence – within one year, researchers say.

Scientists say lockdowns make public get 'pandemic fatigue' quicker

Lockdowns DID cause public to suffer ‘pandemic fatigue’ quicker: Scientists say ‘milder’ restrictions worked better Scientists examined mobile data to see how far people travelled in lockdowns They found people’s movement levels away from home crept up slightly per day But rates accelerated when people were subjected to the harshest lockdown  Authors say policy makers should

Sarcopenic obesity linked to dementia in elderly patients

Obesity, an increasingly prevalent lifestyle disease, often occurs along with poor muscle mass. This condition, called sarcopenic obesity, is evaluated based on the patients’ body mass index (BMI) and handgrip strength. Interestingly, sarcopenic obesity is known to increase the risk of cognitive impairment. Dementia, a cognitive condition where memory, thinking and social abilities progressively decline,

Roche Develops Test Kits to Detect Monkeypox Virus

(Reuters) – Roche on Wednesday said the company and its unit have developed three test kits to detect the monkeypox virus, as the disease spreads in regions outside Africa, where the virus is not normally found. There have been more than 200 suspected or confirmed cases in Europe and North America of monkeypox, according to

New research shows virtual canine comfort can benefit stressed students

Perhaps you can’t teach an old dog new tricks, but new research shows that a novel take on in-person canine visits for stress reduction can provide wellness benefits to students. Associate Professor Christine Tardif-Williams in Brock University’s Department of Child and Youth Studies, along with Associate Professor John-Tyler Binfet of the University of British Columbia

US moves to make antiviral drug more available against COVID

The White House on Thursday announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season. The nation’s first federally backed test-to-treat site is opening Thursday in Rhode Island, providing patients with immediate access to the drug once

Ketamine uses a previously unknown pathway to produce an antidepressant effect, study finds

For the 280 million people suffering from depression globally, relief cannot come fast enough. Monoaminergic antidepressants, including selective serotonin reuptake inhibitors (SSRIs) take weeks to months to take effect and do not work for more than one in three patients. For patients diagnosed with treatment-resistant depression, or in immediate crisis, access to safe, effective, rapid-acting